Involvement of CD44 exon v10 in B-cell activation

Tissue Antigens

Volumn 52, Issue 2, 1998, Pages 99-113

  Rosel M ^a   Foger N ^a   Zoller M ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

B cells; CD44 variant isoforms; Lymphocyte activation; Monocytes

Indexed keywords

CD44V ANTIGEN; GLOBULIN; GLYCOPROTEIN; HERMES ANTIGEN; INTERLEUKIN 1; LECTIN RECEPTOR; LIGAND; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL MATURATION; CONTROLLED STUDY; EXON; LYMPHOCYTE ACTIVATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; STAINING; T LYMPHOCYTE;

ANIMALIA;

EID: 0031854542     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb02273.x     Document Type: Article

References (68)

1. Omary MB, Trowbridge IS, Letarte M, Kagnoff MF, Isacke CM. Structural heterogeneity of human Pgp-1 and its relationship with p85. Immunogenetics 1988: 27: 460-4.
2. Camp RL, Kraus TA, Pure E. Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages. J Cell Biol 1991: 115: 1283-92.
3. Lokeshwar VB, Bourguignon LY. Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. J Biol Chem 1991: 266: 17983-9.
4. Jackson DG, Buckley J, Bell JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 1992: 267: 4732-9.
5. Screaton GR, Bell MV, Bell JI, Jackson DG. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem 1993: 268: 12235-8.
6. Tölg C, Hofmann M, Herrlich P, Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 1993: 21: 1225-9.
7. Hirano H, Screaton GR, Bell MV, Jackson DG, Bell JI, Hodes RJ. CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice. Int Immunol 1994: 6: 49-59.
8. Kennel SJ, Lankford TK, Foote LJ, Shinpock SG, Stringer C. CD44 expression on murine tissues. J Cell Science 1993: 104: 373-82.
9. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994: 124: 71-82.
10. Weber B, Rösel M, Arch R, Möller P, Zöller M. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations. Differentiation 1996: 60: 17-29.
11. Ruiz P, Schwärzler C, Günthert U. CD44 Isoforms during differentiation and development. Bioessays 1995: 17: 17-24.
12. Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 1991: 3: 347-50.
13. Günthert U. CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 1993: 184: 47-63.
14. Jalkanen S, Bargatze RF, de los Toyos J, Butcher EC. A lymphoid cell surface protein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 1986: 16: 1195-1202.
15. Picker LJ, Nakache M, Butcher EC. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 1989: 109: 927-37.
16. Zhou DFH, Ding JF, Picker LF, Bargatze RF, Butcher EC, Goeddel DV. Molecular cloning and expression of Pgp-1 - the mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor. J Immunol 1989: 143: 3390-5.
17. Toyama-Sorimachi N, Sorimachi H, Tobita Y et al. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation. J Biol Chem 1995: 270: 7437-44.
18. Murakami S, Miyake K, June CH, Kincade PW, Hodes RJ. 1L-5 induces a PRP-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J Immunol 1990: 145: 3618-27.
19. Miyake K, Medina KL, Hayashi SI, Ono S, Hamaoka T, Kincade PW. Monoclonal antibodies to Pgp-1/CD44 block lymphohemopoiesis in long-term bone marrow cultures. J Exp Med 1990: 171: 477-88.
20. Siczkowski M, Andrew T, Amos S, Gordon MY. Hyaluronic acid regulates the function and distribution of sulfated glycosaminoglycans in bone marrow stromal cultures. Exp Hematol 1993: 21: 126-30.
21. Sugimoto K, Tsurumaki Y, Hoshi H et al. Effects of anti-CD44 monoclonal antibody on adhesion of erythroid leukemic cells (ELM-1-1) to hematopoietic supportive cells (MS-5): CD44, but not hyaluronate-mediated cell-cell adhesion. Exp Hematol 1994: 22: 488-94.
22. Kincade PW, He Q, Ishihara K, Miyake K, Lesley J, Hyman R. CD44 and other cell interaction molecules contributing to B lymphopoesis. Curr Top Microbiol Immunol 1993: 184: 215-22.
23. Wu L, Kincade PW, Shortman K. The CD44 expressed on the earliest intrathymic precursor population functions as a thymus homing molecule but does not bind to hyaluronate. Immunol Lett 1993: 38: 69-75.
24. Camp RL, Scheynius A, Johansson C, Pure E. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 1993: 178: 497-507.
25. Mikecz K, Brennan FR, Kim JH, Glant TT. The role of adhesion molecules in the development of autoimmune arthritis. Scand J Rheumatol 1995: (Suppl 101): 99-106.
26. Huet S, Groux H, Caillou B, Valentin H, Prieur AM, Bernard A. CD44 contributes to T cell activation. J Immunol 1989: 143: 798-801.
27. Shimizu Y, van Seventer GA, Siraganian R, Wahl L, Shaw S. Dual role of the CD44 molecule in T-cell adhesion and activation. J Immunol 1989: 143: 2457-63.
28. Denning SM, Le PT, Singer KH, Haynes BF. Antibodies against the CD44 lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol 1990: 144: 7-15.
29. Pierres A, Lipcey C, Mawas C, Olive D. A unique CD44 monoclonal antibody identifies a new T cell activation pathway. Eur J Immunol 1992: 22: 413-7.
30. Galandrini R, Albi N, Tripodi G et al. Antibodies to CD44 trigger effector functions of human T cell clones. J Immunol 1993: 150: 4225-31.
31. Conrad P, Rothman BL, Kelley KA, Blue ML. Mechanism of peripheral T cell activation by coengagement of CD44 and CD2. J Immunol 1992: 149: 1833-39.
32. Funaro A, Spagnoli GC, Momo M, Knapp W, Malavasi F. Stimulation of T cells via CD44 requires LFA-1 interactions and IL-2 production. Hum Immunol 1994: 40: 267-78.
33. Naujokas MF, Morin M, Anderson MS, Peterson M, Miller J. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 1993: 74: 257-68.
34. Verdrengh M, Holmdahl R, Tarkowski A. Administration of antibodies to hyaluronanreceptor (CD44) delays the start and ameliorates the severity of collagen arthritis. Scand J Immunol 1995: 42: 353-8.
35. Webb DS, Shimizu Y, van Seventer GA, Shaw S, Gerrard TL. CD44 and CD45: physiological triggers of human monocyte TNF and IL-1 release. Science 1990: 14: 1295-7.
36. Noble PW, Lake FR, Henson PM, Riches DW. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrois factor-alpha-dependent mechanism in murine macrophages. J Clin Invest 1993: 81: 2368-77.
37. Gruber MF, Webb DS, Gerrard TL. Stimulation of human monocytes via CD45, CD44 and LFA-3 triggers macrophage-colony-stimulating factor production. Synergism with lipopolysaccharide and IL-1 beta. J Immunol 1992: 15: 1113-8.
38. Sommer F, Huber M, Röllinghoff M, Lohoff M. CD44 plays a co-stimulatory role in murine T cell activation: ligation of CD44 selectively co-stimulates IL-2 production, but not proliferation in TCR-stimulated murine Th1 cells. Int Immunol 1995: 7: 1779-86.
39. Taher EI, Taher LS, Griffioen AW, Schilder-Tol EJM, Borst J, Pals ST. Signaling through CD44 is mediated by tyrosine kinases. J Biol Chem 1996: 271: 2863-7.
40. Guo Y, Wu Y, Shinde S, Sy MS, Aruffo A, Liu Y. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. Exp Med 1996: 184: 955-61.
41. Arch R, Wirth K, Hofmann M et al. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992: 257: 682-5.
42. Galluzzo E, Albi N, Fiorruci S et al. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur J Immunol 1995: 25: 2932-8.
43. Levesque MC, Haynes BF. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J Immunol 1996: 156: 1557-65.
44. Koopman G, Heider KH, Horst E et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993: 177: 897-904.
45. Bennett KL, Jackson DG, Simon JC et al. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995: 128: 687-98.
46. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 1995: 128: 673-85.
47. Wagner SN, Wagner C, Reinhold U, Funk R, Zöller M, Goos M. Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes. J Invest Dermatol (In press).
48. Rösel M, Seiter S, Zöller M. CD44v10 expression in the mouse and functional activity in delayed type hypersensitivity. J Cell Physiol 1997: 171: 305-17.
49. Zöller M, Schumacher J, Reed J, Maier-Borst W, Matzku S. Establishment and characterization of monoclonal antibodies against an octahedral gallium chelate. J Nucl Med 1992: 33: 1366-72.
50. Björck L, Kronvall G. Purification and some properties of streptococcal Protein G: a novel IgG binding reagent. J Immunol 1984: 133: 969-74.
51. 2 fragments from mouse IgG of various subclasses. J Immunol Methods 1983: 56: 235-43.
52. Traunecker A, Dolder B, Karjalainen K. A novel approach for preparing anti-T cell receptor constant region antibodies. Eur J Immunol 1986: 16: 851-4.
53. Zawadzki V, Perschl A, Rösel M, Hekele A, Zöller M. Blockade of metastasis formation by CD44 receptor globulin. Int J Cancer 1998: 75: 919-24.
54. Henderson AJ, Johnson A, Dorshkind K. Functional characterization of two stromal cell lines that support B lymphopoiesis. J Immunol 1990: 145: 423-8.
55. Wysocki LJ, Sato VL. Panning for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A 1978: 75: 2844-8.
56. Engvall E, Perlman P. Enzyme-linked immunoadsorbant assay ELISA. Detection of IgG. Immunochemistry 1971: 8: 871-4.
57. Lefkovits I, Waldmann H. Limiting dilution analysis of cells in the immune system. Cambridge: University Press, 1978.
58. Wortis HH, Teutsch M, Higer M, Zheng J, Parker DC. B cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B cell phenotypes. Proc Natl Acad Sci U S A 1995: 92: 3348-52.
59. Snapper CM, Rosas FR, Jin L, Wortham C, Kehry MR, Mond JJ. Bacterial lipoproteins may substitute for cytokines in the humoral immune response to T cell-independent type II antigens. J Immunol 1995: 155: 5582-9.
60. Mond JJ, Lees A, Snapper CM. T cell-independent antigens type 2. Annu Rev Immunol 1995: 13: 655-92.
61. Mamchak AA, Hodgkin PD. The one signal theory of B cell activation revisited: a role for surface immunoglobulin in regulating T-independent antibody responses? Immunol Cell Biol 1995: 73: 266-71.
62. Tohma S, Lipsky PE. Analysis of the mechanisms of T cell-dependent polydonal activation of human B cells. Induction of human B cell responses by fixed activated T cells. J Immunol 1991: 146: 2544-52.
63. Maltzman JS, Carmen JA, Monroe JG. Transcriptional regulation of ICAM-1 gene in antigen receptor- and phorbol ester-stimulated B lymphocytes: role for transcription factor EGR1. J Exp Med 1996: 183: 1747-59.
64. Tanaka AS, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S. T cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 1993: 361: 79-82.
65. Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996: 271: 509-12.
66. Günthert U, Hofmann M, Rudy W et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991: 65: 13-24.
67. Herrlich P, Zöller M, Pals ST, Ponta H. CD44 splice variants: metastases meet lymphocytes. Immunol Today 1993: 14: 395-9.
68. Zöller M. Joint features of metastasis formation and lymphocyte maturation and activation. Curr Top Microbiol Immunol 1996: 213: 215-47.